Alzheimer’s

The study supports the idea that components in the human blood can modulate the formation of new brain cells.

Blood-based markers may reveal Alzheimer's disease ten years before symptoms show.

This treatment option is the latest therapy to target.

A clue to the molecular cause of Alzheimer’s.

A modified immune protein harming brain connections is much more common in the brains of women with Alzheimer’s.

If we can find these individuals early enough, we’ll have a better chance of seeing if the drugs are effective.

The discovery provides a new therapeutic target to prevent the onset of neurodegenerative diseases.

Separating densely packed molecules before imaging makes them visible for the first time.

Protein ‘traffic jam' in neurons linked to neurodegeneration.

Boosting neuron production could be a viable strategy for treating AD patients.

The Brain’s drainage system in 3 dimensions.

This is the first large-scale study of somatic mutations in human brains.